News

BofA Raises Fed Rate Cut Forecast to 75 Basis Points in Q4

BofA Raises Fed Rate Cut Forecast to 75 Basis Points in Q4

BofA Updates Projections for Federal Reserve Rate Cuts

BofA Global Research has recently revised its expectations concerning the Federal Reserve's interest rate cuts for the remainder of the year. The financial institution anticipates a significant reduction of 75 basis points, prompted by the U.S. central bank’s announcement of a larger-than-expected half-percentage-point cut. This decision supports the Fed's goal of maintaining low unemployment rates while inflation continues to trend downward.

Effects of Recent Rate Cuts

The Federal Reserve's latest decision, highlighted by Chair Jerome Powell, indicates a move towards more aggressive monetary easing. In light of this new approach, BofA has adjusted its earlier forecast. Initially, the institution had expected two smaller cuts of 25 basis points each in the upcoming November and December meetings. Now, however, the revised outlook points to a single reduction of 75 basis points in the fourth quarter.

Future Rate Cut Forecasts

BofA Global Research isn't stopping with just this quarterly cut. Looking ahead, they're predicting an additional cumulative reduction of 125 basis points anticipated in 2025. This would bring the terminal rate down to a target range of 2.75% to 3.00%, marking a significant decrease from the current Fed funds target rate, which is sitting between 4.75% and 5.00%.

Economic Analysis from BofA Economists

The economic team at BofA has indicated that deeper rate cuts seem unavoidable. They believe the central bank is likely to enter into a more extended cycle of cuts instead of adopting a hawkish stance following such a substantial reduction. Their insights stress the importance of achieving a careful balance to ensure ongoing economic stability.

Goldman Sachs' Alternative Predictions

In a related analysis, Goldman Sachs has maintained its expectations regarding forthcoming reductions, forecasting two cuts of 25 basis points each during the November and December meetings. Additionally, they foresee a trend of consecutive cuts beginning in November 2024, potentially lasting through June 2025, which could lead to a terminal rate adjustment to the range of 3.25% to 3.50% by mid-2025.

Goldman Sachs’ Assessment of Future Cuts

The economic outlook from Goldman Sachs emphasizes a sense of urgency, particularly with the recent half-percentage-point cut. They note that the accelerated pace of projected cuts in 2025 is likely to result in a series of regular reductions, fundamentally altering the economic landscape moving forward.

Federal Reserve's Projections and Considerations

According to the latest projections from Fed policymakers, another decrease of half a percentage point in the benchmark interest rate is expected by the end of 2024. Furthermore, they predict a total decline of one complete percentage point in 2025, alongside an additional reduction of half a percentage point the following year. However, they do warn that such long-term forecasts come with considerable uncertainty, underscoring the challenges involved in accurately predicting economic conditions.

Final Thoughts

The Federal Reserve plays a critical role in managing economic stability, particularly amid changing inflation rates. As BofA and other financial institutions adjust their forecasts, the anticipated impact of these cuts is likely to resonate throughout the broader economy, influencing the financial strategies of both individuals and businesses in the future.

Frequently Asked Questions

What is BofA's updated forecast for Fed rate cuts?

BofA now expects the Federal Reserve to implement a 75 basis point cut in the fourth quarter, exceeding prior predictions.

What prompted BofA to revise its forecast?

The revision comes on the heels of a significant half-percentage-point rate cut announced by the Federal Reserve.

How does Goldman Sachs assess the Fed's potential rate cuts?

Goldman Sachs anticipates two cuts of 25 basis points each later this year and foresees the possibility of successive cuts in the coming years.

What is BofA's estimated terminal rate?

BofA estimates that the terminal rate might drop to between 2.75% and 3.00% following additional cuts.

What factors influence the Fed's decisions on rate cuts?

Current inflation trends, unemployment rates, and general economic conditions heavily influence the Fed's decisions regarding rate cuts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 1

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 1

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

Combining Forces: Waters Corporation and BD to Lead Diagnostics

Updated Category News Views 331

Exciting Merger in the Life Sciences Sector In a significant move for the life sciences industry, Waters Corporation (NYSE: WAT) has officially announced its plans to merge with BD (Becton, Dickinson and Company) (NYSE: BDX). This merger aims to create a leading entity in the fields of regulated and high-volume testing. The combination is expected to harness the strengths...

Continue Reading
Citius Oncology Strengthens LYMPHIR Launch with New Partnership

Updated Category News Views 109

Citius Oncology Reinforces Distribution for LYMPHIR Citius Oncology, Inc. (Nasdaq: CTOR), a leading company in oncology therapeutics, has taken a significant step by partnering with Cencora, a global provider of pharmaceutical solutions. The newly signed distribution services agreement is aimed at enhancing commercial infrastructure and ensuring the successful launch of...

Continue Reading
Exploring Growth in Low-Code Development Platforms

Updated Category News Views 242

Surging Growth in Low-Code Development Platforms The demand for low-code development platforms is on the rise, with projected growth from USD 26.30 billion in 2025 up to USD 67.12 billion by 2030, at an impressive CAGR of 20.61%. This surge is primarily fueled by organizations adopting hybrid and multi-cloud strategies, making low-code tools essential for modernizing...

Continue Reading
Foresee Pharmaceuticals Unveils Promising Results for Linvemastat

Updated Category News Views 58

Foresee Pharmaceuticals Announces Groundbreaking Phase 1 Results Foresee Pharmaceuticals (TPEx: 6576) is excited to share notable updates regarding its Phase 1 clinical trial of linvemastat (FP-020), a distinctive and selective oral MMP-12 inhibitor. The trial, focused on assessing safety, tolerability, and pharmacokinetics, has been successfully completed and has...

Continue Reading
Unlocking Spring’s Real Estate Potential with Mistoria Group

Updated Category News Views 302

Why May is the Optimal Time for Real Estate Transactions As the weather warms and spring settles in, the real estate market bursts with activity. Leading property experts suggest that May is the prime month to either buy or sell a home. Mish Liyanage, the CEO of Mistoria Group, emphasizes that emerging market trends provide compelling reasons for homeowners and potential...

Continue Reading